Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 30, 2015
Issued Date -
N/A
app pub date -
May 25, 2012
filing date -
May 25, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention relates to compounds that inhibit KIR2DL1, 2 and/or 3 polypeptide comprising compounds (e.g., anti-KIR2DL1, 2, and/or 3 antibodies) that neutralize NK cell inhibitory receptors and methods of using such compounds and compositions containing in the treatment and prevention of inflammatory or autoimmune disorders.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully